GREENFIELD, Ind.--(BUSINESS WIRE)--With the U.S. Food and Drug Administration (FDA) approval of Zorbiumâ„¢ (buprenorphine transdermal solution), Elanco Animal Health (NYSE: ELAN) expands its pain ...
FDA issues approval for new, prescription medication to control postoperative pain associated with surgical procedures in cats, expanding Elanco’s pain portfolio. A new long-acting medication to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback